-
1دورية أكاديمية
المؤلفون: Colombat, P., Brousse, N., Salles, G., Morschhauser, Franck, Brice, P., Soubeyran, P., Delwail, V., Deconinck, E., Haioun, C., Foussard, C., Sebban, C., Tilly, H., Thieblemont, C., Bergougnoux, L., Lazreg, F., Solal-Celigny, P.
المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365
مصطلحات موضوعية: rituximab, low-burden, induction monotherapy, follicular lymphoma
العلاقة: Annals of Oncology; Ann. Oncol.; http://hdl.handle.net/20.500.12210/82544Test
-
2
المؤلفون: Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicolas, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-François, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A, Abdel-Samad N, Abdo-Matkiwsky M, Abraham J, Abrisqueta P, Anglaret B, Barnes JA, Benbrahim O, Bierman PJ, Bonnet C, Brault P, Bron D, Brooks BJ Jr, Byeff P, Casanova M, Cheung M, Choudhary Y, Comeau T, Cooper B, Couban S, Cox MC, Crump M, Deau Fischer B, Deconinck E, Deeren D, de la Cruz Vicente F, Delarue R, Del Campo R, Delmer A, Delwail V, Duggan PR, Eisenmann DJRM, El Yamani A, Eradat HA, Fabbro M, Farber C, Fisher DC, Fleischman RA, Fleck E, Fornecker LM, Foussard C, Gabarre J, Gaffar YA, Gallardo D, Ghazal H, Giagounidis A, Gill K, Glaisner S, Gonzalez H, Greenberg RH, Goubran Messiha H, Goy A, Gressin R, Gyan E, Hart LL, Hatake K, Hiddemann W, Hodossy B, Horkheimer I, Hoyer RJ, Huebel K, Ishikawa T, Izutsu K, Jardel H, Jhangiani HS, Johnson N, Joly B, Jourdan E, Kargar Samani K, Kato K, Kiguchi T, Kobayashi T, Kohser F, Koike M, Kouroukis C T, Laferriere N, Lamy de la Chapelle T, Landau DA, Lawler WE, Lemieux B, Levitan DA, Longree L, Lopez J, Mace J, Maerevoet M, Maigre M, Marjanovic Z, Michel J, Mounier C, Muntanola A, Ngirabacu MC, Nicolas-Virelizier E, Novelli S, Offner F, Palomera L, Pandit LH, Panwalkar A, Pierre P, Pignon JM, Pinto A, Plöger C, Pranger D, Quick DP, Reyes EA, Robin V, Robu D, Rodriguez Salazar MJ, Rosen PJ, Rosenbluth J, Sadot-Lebouvier S, Sangha R, Segota Z, Shapira I, Shtivelband M, Simon M, Soekler M, Soubeyran P, Taper J, Tereblo HR, Terol MJ, The AS, Ueda Y, van den Neste E, van Eygen K, van Hoof A, Vanstraelen G, Verner E, Warburton P, Yamamoto G, Yokoyama H, Zerazhi H, Zinzani PL.
المساهمون: Morschhauser, Franck, Fowler, Nathan H, Feugier, Pierre, Bouabdallah, Reda, Tilly, Hervé, Palomba, M Lia, Fruchart, Christophe, Libby, Edward N, Casasnovas, Rene-Olivier, Flinn, Ian W, Haioun, Corinne, Maisonneuve, Hervé, Ysebaert, Loic, Bartlett, Nancy L, Bouabdallah, Kamal, Brice, Pauline, Ribrag, Vincent, Daguindau, Nicola, Le Gouill, Steven, Pica, Gian M, Martin Garcia-Sancho, Alejandro, López-Guillermo, Armando, Larouche, Jean-Françoi, Ando, Kiyoshi, Gomes da Silva, Maria, André, Marc, Zachée, Pierre, Sehn, Laurie H, Tobinai, Kensei, Cartron, Guillaume, Liu, David, Wang, Jianming, Xerri, Luc, Salles, Gilles A, Abdel-Samad N, Abdo-Matkiwsky M, Abraham J, Abrisqueta P, Anglaret B, Barnes JA, Benbrahim O, Bierman PJ, Bonnet C, Brault P, Bron D, Brooks BJ Jr, Byeff P, Casanova M, Cheung M, Choudhary Y, Comeau T, Cooper B, Couban S, Cox MC, Crump M, Deau Fischer B, Deconinck E, Deeren D, de la Cruz Vicente F, Delarue R, Del Campo R, Delmer A, Delwail V, Duggan PR, Eisenmann DJRM, El Yamani A, Eradat HA, Fabbro M, Farber C, Fisher DC, Fleischman RA, Fleck E, Fornecker LM, Foussard C, Gabarre J, Gaffar YA, Gallardo D, Ghazal H, Giagounidis A, Gill K, Glaisner S, Gonzalez H, Greenberg RH, Goubran Messiha H, Goy A, Gressin R, Gyan E, Hart LL, Hatake K, Hiddemann W, Hodossy B, Horkheimer I, Hoyer RJ, Huebel K, Ishikawa T, Izutsu K, Jardel H, Jhangiani HS, Johnson N, Joly B, Jourdan E, Kargar Samani K, Kato K, Kiguchi T, Kobayashi T, Kohser F, Koike M, Kouroukis C T, Laferriere N, Lamy de la Chapelle T, Landau DA, Lawler WE, Lemieux B, Levitan DA, Longree L, Lopez J, Mace J, Maerevoet M, Maigre M, Marjanovic Z, Michel J, Mounier C, Muntanola A, Ngirabacu MC, Nicolas-Virelizier E, Novelli S, Offner F, Palomera L, Pandit LH, Panwalkar A, Pierre P, Pignon JM, Pinto A, Plöger C, Pranger D, Quick DP, Reyes EA, Robin V, Robu D, Rodriguez Salazar MJ, Rosen PJ, Rosenbluth J, Sadot-Lebouvier S, Sangha R, Segota Z, Shapira I, Shtivelband M, Simon M, Soekler M, Soubeyran P, Taper J, Tereblo HR, Terol MJ, The AS, Ueda Y, van den Neste E, van Eygen K, van Hoof A, Vanstraelen G, Verner E, Warburton P, Yamamoto G, Yokoyama H, Zerazhi H, Zinzani PL., Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Department of Lymphoma and Myeloma [Houston, TX, USA], The University of Texas M.D. Anderson Cancer Center [Houston], Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d’Hématologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Institut d'Hématologie de Basse-Normandie (IHBN), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN)-Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-UNICANCER, Service d'Hématologie Clinique (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Unité des hémopathies lymphoïdes [CHU Henri Mondor], CHU Henri Mondor, Service d’Onco-Hématologie [La Roche sur Yon], Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Service Hématologie - IUCT-Oncopole [CHU Toulouse], Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle IUCT [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service d'hématologie [CHU Bordeaux], CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service d'onco-hématologie [AP-HP Hôpital Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département d'hématologie [Gustave Roussy], Institut Gustave Roussy (IGR), Centre Hospitalier Annecy-Genevois [Saint-Julien-en-Genevois], Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Service d'Hématologie Clinique [Hôpital Hôtel Dieu, Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes)-Hôpital Hôtel Dieu, Service Hématologie [CH Métropole Savoie, Chambery], Centre Hospitalier Métropole Savoie [Chambéry], Département d'Hématologie [CHU de Montpellier], Centre Hospitalier Universitaire de Montpellier (CHU Montpellier ), Département d'Hématologie [CH Lyon-Sud], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), RELEVANCE Trial Investigators : Abdel-Samad N, Abdo-Matkiwsky M, Abraham J, Abrisqueta P, Anglaret B, Barnes JA, Benbrahim O, Bierman PJ, Bonnet C, Brault P, Bron D, Brooks BJ Jr, Byeff P, Casanova M, Cheung M, Choudhary Y, Comeau T, Cooper B, Couban S, Cox MC, Crump M, Deau Fischer B, Deconinck E, Deeren D, de la Cruz Vicente F, Delarue R, Del Campo R, Delmer A, Delwail V, Duggan PR, Eisenmann DJRM, El Yamani A, Eradat HA, Fabbro M, Farber C, Fisher DC, Fleischman RA, Fleck E, Fornecker LM, Foussard C, Gabarre J, Gaffar YA, Gallardo D, Ghazal H, Giagounidis A, Gill K, Glaisner S, Gonzalez H, Greenberg RH, Goubran Messiha H, Goy A, Gressin R, Gyan E, Hart LL, Hatake K, Hiddemann W, Hodossy B, Horkheimer I, Hoyer RJ, Huebel K, Ishikawa T, Izutsu K, Jardel H, Jhangiani HS, Johnson N, Joly B, Jourdan E, Kargar Samani K, Kato K, Kiguchi T, Kobayashi T, Kohser F, Koike M, Kouroukis C T, Laferriere N, Lamy de la Chapelle T, Landau DA, Lawler WE, Lemieux B, Levitan DA, Longree L, Lopez J, Mace J, Maerevoet M, Maigre M, Marjanovic Z, Michel J, Mounier C, Muntanola A, Ngirabacu MC, Nicolas-Virelizier E, Novelli S, Offner F, Palomera L, Pandit LH, Panwalkar A, Pierre P, Pignon JM, Pinto A, Plöger C, Pranger D, Quick DP, Reyes EA, Robin V, Robu D, Rodriguez Salazar MJ, Rosen PJ, Rosenbluth J, Sadot-Lebouvier S, Sangha R, Segota Z, Shapira I, Shtivelband M, Simon M, Soekler M, Soubeyran P, Taper J, Tereblo HR, Terol MJ, The AS, Ueda Y, van den Neste E, van Eygen K, van Hoof A, Vanstraelen G, Verner E, Warburton P, Yamamoto G, Yokoyama H, Zerazhi H, Zinzani PL., Bernardo, Elizabeth, CHU Henri Mondor [Créteil], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille, Centre Régional de Lutte contre le Cancer François Baclesse [Caen] (UNICANCER/CRLC), UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Université de Caen Normandie (UNICAEN), Normandie Université (NU), Centre Hospitalier Départemental Vendée, Service d'Hématologie [IUCT Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)
المصدر: New England Journal of Medicine
New England Journal of Medicine, 2018, 379 (10), pp.934-947. ⟨10.1056/nejmoa1805104⟩
New England Journal of Medicine, Massachusetts Medical Society, 2018, 379 (10), pp.934-947. ⟨10.1056/nejmoa1805104⟩مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Neutropenia, Intention to Treat Analysi, Follicular lymphoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, Skin Diseases, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Maintenance therapy, immune system diseases, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Survival rate, Lenalidomide, Lymphoma, Follicular, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, business.industry, Skin Disease, General Medicine, Middle Aged, medicine.disease, 3. Good health, Intention to Treat Analysis, Thalidomide, Survival Rate, Regimen, 030220 oncology & carcinogenesis, Rituximab, Female, business, Febrile neutropenia, 030215 immunology, medicine.drug, Human
وصف الملف: STAMPA; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3989a335983ccc37800421665ae98b9Test
http://hdl.handle.net/11585/674313Test -
3دورية أكاديمية
المؤلفون: Colombat, P., Brousse, N., Salles, G., Morschhauser, Franck, Brice, P., Soubeyran, P., Delwail, V., Deconinck, E., Haioun, C., Foussard, C., Sebban, C., Tilly, H., Thieblemont, C., Bergougnoux, L., Lazreg, F., Solal-Celigny, P.
المساهمون: Université de Lille, CHU Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées (GRITA) - ULR 7365
مصطلحات موضوعية: rituximab, low-burden, induction monotherapy, follicular lymphoma
العلاقة: Annals of Oncology; Ann. Oncol.; http://hdl.handle.net/20.500.12210/82545Test
-
4دورية أكاديمية
المؤلفون: Federico M, Bellei M, Marcheselli L, Luminari S, Lopez Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal Celigny P., ARCAINI, LUCA
المساهمون: Federico, M, Bellei, M, Marcheselli, L, Luminari, S, Lopez Guillermo, A, Vitolo, U, Pro, B, Pileri, S, Pulsoni, A, Soubeyran, P, Cortelazzo, S, Martinelli, G, Martelli, M, Rigacci, L, Arcaini, Luca, Di Raimondo, F, Merli, F, Sabattini, E, Mclaughlin, P, Solal Celigny, P.
مصطلحات موضوعية: Follicular Lymphoma, prognosi, survival
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/19652063; info:eu-repo/semantics/altIdentifier/wos/WOS:000270019900020; volume:27; issue:27; firstpage:4555; lastpage:4562; numberofpages:8; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11571/150700Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-70349745593
-
5دورية أكاديمية
المؤلفون: SOLAL CELIGNY P, ROY P, COLOMBAT P, WHITE J, ARMITAGE JO, ARRANZ SAEZ R, AU WY, BELLEI, Monica, BRICE P, CABALLERO D, COIFFIER B, CONDE GARCIA E, DOYEN C, FEDERICO, Massimo, FISHER RI, GARCIA CONDE JF, GUGLIELMI C, HAGENBEEK A, HAIOUN C, LEBLANC M, LISTER AT, LOPEZ GUILLERMO A, MCLAUGHLIN P, MILPIED N, MOREL P, MOUNIER N, PROCTOR SJ, ROHATINER A, SMITH P, SOUBEYRAN P, TILLY H, VITOLO U, ZINZANI PL, ZUCCA E, MONTSERRAT E.
المساهمون: SOLAL CELIGNY, P, Roy, P, Colombat, P, White, J, Armitage, Jo, ARRANZ SAEZ, R, Au, Wy, Bellei, Monica, Brice, P, Caballero, D, Coiffier, B, CONDE GARCIA, E, Doyen, C, Federico, Massimo, Fisher, Ri, GARCIA CONDE, Jf, Guglielmi, C, Hagenbeek, A, Haioun, C, Leblanc, M, Lister, At, LOPEZ GUILLERMO, A, Mclaughlin, P, Milpied, N, Morel, P, Mounier, N, Proctor, Sj, Rohatiner, A, Smith, P, Soubeyran, P, Tilly, H, Vitolo, U, Zinzani, Pl, Zucca, E, Montserrat, E.
مصطلحات موضوعية: Follicular lymphoma, International Prognostic Index (IPI), prognosis
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/15126323; info:eu-repo/semantics/altIdentifier/wos/WOS:000223544000014; volume:104 (5); firstpage:1258; lastpage:1265; journal:BLOOD; http://hdl.handle.net/11380/584210Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-4444326818
-
6
المؤلفون: Coiffier, B, Osmanov, E, Hong, X, Scheliga, A, Mayer, J, Offner, F, Rule, S, Teixeira, A, Walewski, J, de Vos, S, Crump, M, Shpilberg, O, Esseltine, D, Zhu, E, Enny, C, Theocharous, P, van de Velde, H, Elsayed, Y, Zinzani, P, Abdulkadyrov, K, Afanasiev, B, Aguayo Gonzalez, A, Andre, M, Belada, D, Ben Yehuda, D, Bezares, R, Biakhov, M, Bolam, S, Borbenyi, Z, Bron, D, Buckstein, R, Bumbea, H, Caballero Barrigon, M, Campos, L, Cantonetti, M, Capra Zanella, M, Christiansen, N, Cohen, G, Colita, N, Cosgriff, T, Culligan, D, Del Giglio, A, Dichmann, R, Dietzfelbinger, H, Digumarti, R, Dmoszynska, A, Domnikova, N, Dubinsky, P, Dunaev, Y, Easow, J, Eberwine, S, Economopoulos, T, Egyed, M, Ellerton, J, Eom, H, Farmer, L, Fenske, T, Fields, P, Fillet, G, Frank, R, Gaisarova, G, Garicochea, B, Gasztonyi, Z, Gavish, I, Gheorghita, E, Gladkov, O, Goldberg, V, Golenkov, A, Gomez Almaguer, D, Gonzalez Barca, E, Guan, Z, Gupta, S, Hellmann, A, Hermann, R, Honkanen, T, Hu, E, Huang, X, Hudecek, J, Illes, A, Intragumtornchai, T, Jedrzejczak, W, Jones, L, Jootar, S, Kahanic, S, Karamanesht, E, Ke, X, Khuageva, N, Kim, W, Kimby, E, Komisarenko, V, Kouroukis, T, Kuliczkowski, K, Kuzina, L, Kyselyova, M, Labanca, V, Lange, A, Le Gouill, S, Leahy, M, Liberati, A, Linden, O, Liu, T, Lubennikov, V, Lundin, J, Lysa, T, Lysenko, I, Lytvyn, I, Makhson, A, Manikhas, G, Masliak, Z, Mcintyre, R, Medvedeva, N, Mena, R, Merkulov, V, Mesters, R, Milpied, N, Min, Y, Moezi, M, Mohrbacher, A, Mollee, P, Morgan, D, Morschhauser, F, Mysanikov, A, Nagler, A, Nair, S, Naparstek, E, Nawarawong, W, Noga, S, Oliveira, I, Okada, C, Oriol Rocafiguera, A, Page, R, Papajik, T, Pasquini, R, Patel, M, Patel, R, Paton, E, Pavlov, V, Pospelova, T, Prasad, S, Pylypenko, H, Raposo, J, Rekhtman, G, Rivas, S, Robak, T, Saba, S, Salles, G, Saltzman, M, Samoilova, O, Samuels, B, Sanani, S, Sebban, C, Silva da Gomes, M, Shen, Z, Shi, Y, Shtalrid, M, Siritanaratkul, N, Skotnicki, A, Solal Celigny, P, Soubeyran, P, Spencer, A, Stevens, D, Suh, C, Sulek, K, Suvorov, A, Szer, J, Theunissen, K, To Bik, L, Tothova, E, Trneny, M, Van De Velde, A, Van Hoof, A, Van Steenweghen, S, Vanhatalo, S, Varma, S, Vidyasagar, M, Vilchevskaya, K, Vitolo, U, Wang, H, Warzocha, K, Wild, A, Zachee, P, Zanichelli, M, Zhang, W, Zoppegno, L, Zoumbos, N
المساهمون: Coiffier B., Osmanov E.A., Hong X., Scheliga A., Mayer J., Offner F., Rule S., Teixeira A., Walewski J., de Vos S., Crump M., Shpilberg O., Esseltine D.L., Zhu E., Enny C., Theocharous P., van de Velde H., Elsayed Y.A., Zinzani P.L., LYM-3001 study investigators
المصدر: The Lancet. Oncology. 12(8)
مصطلحات موضوعية: Oncology, Male, Lymphoma, Settore MED/06 - Oncologia Medica, Follicular lymphoma, Bortezomib, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Maintenance therapy, Prednisone, immune system diseases, Recurrence, hemic and lymphatic diseases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Lymphoma, Follicular, Multiple myeloma, Infusion Pumps, Aged, 80 and over, Middle Aged, Boronic Acids, 3. Good health, 030220 oncology & carcinogenesis, Pyrazines, Rituximab, Female, medicine.drug, Murine-Derived, Adult, medicine.medical_specialty, rituximab-naive, Antineoplastic Agents, Antibodies, Disease-Free Survival, 03 medical and health sciences, Young Adult, follicular lymphoma, Internal medicine, Neoplasm Staging, Humans, Aged, medicine, business.industry, Follicular, medicine.disease, Clinical trial, rituximab-sensitive, Immunology, business, Settore MED/15 - Malattie del Sangue, 030215 immunology
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13b94128df5db75a9919f1ae0f67a71Test
https://pubmed.ncbi.nlm.nih.gov/21724461Test -
7دورية أكاديمية
المؤلفون: Colombat, P.1, Brousse, N.2, Salles, G.3, Morschhauser, F.4, Brice, P.5, Soubeyran, P.6, Delwail, V.7, Deconinck, E.8, Haioun, C.9, Foussard, C.10, Sebban, C.11, Tilly, H.12, Thieblemont, C.5, Bergougnoux, L.13, Lazreg, F.13, Solal-Celigny, P.14
المصدر: Annals of Oncology. Sep2012, Vol. 23 Issue 9, p2380-2385. 6p. 1 Diagram, 1 Chart, 4 Graphs.
مصطلحات موضوعية: *LYMPHOMA treatment, *CANCER immunotherapy, *RITUXIMAB, *CANCER chemotherapy, *FOLLOW-up studies (Medicine), *DRUG dosage, *TREATMENT effectiveness
-
8
المؤلفون: Alessandro Pulsoni, Pierre Soubeyran, Francesco Merli, Maurizio Martelli, Umberto Vitolo, Elena Sabattini, Peter McLaughlin, Giovanni Martinelli, Luca Arcaini, Luigi Rigacci, Armando López-Guillermo, Stefano Luminari, Barbara Pro, Stefano Pileri, Francesco Di Raimondo, Luigi Marcheselli, Massimo Federico, Philippe Solal-Celigny, Sergio Cortelazzo, Monica Bellei
المساهمون: Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, Pro B, Pileri S, Pulsoni A, Soubeyran P, Cortelazzo S, Martinelli G, Martelli M, Rigacci L, Arcaini L, Di Raimondo F, Merli F, Sabattini E, McLaughlin P, Solal-Céligny P.
مصطلحات موضوعية: Oncology, Adult, Cancer Research, Prognostic factor, Pathology, medicine.medical_specialty, PREDICTION, Follicular lymphoma, FLIPI, follicular lymphoma, prognostic factor, LOW-GRADE LYMPHOMA, Risk Assessment, Disease-Free Survival, Young Adult, SERUM BETA-2-MICROGLOBULIN, International Prognostic Index, Predictive Value of Tests, Internal medicine, medicine, Humans, NON-HODGKINS-LYMPHOMA, LOW-GRADE LYMPHOMA, SERUM BETA-2-MICROGLOBULIN, MULTIVARIATE-ANALYSIS, RESPONSE CRITERIA, SURVIVAL, MODEL, RITUXIMAB, PREDICTION, TRIAL, NON-HODGKINS-LYMPHOMA, RITUXIMAB, Young adult, MULTIVARIATE-ANALYSIS, Lymphoma, Follicular, RESPONSE CRITERIA, Aged, Aged, 80 and over, End point, business.industry, Cancer, Middle Aged, medicine.disease, Prognosis, Lymphoma, MODEL, Predictive value of tests, SURVIVAL, Disease Progression, TRIAL, business
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62477fa8ddaf657f00dee004bb3cdadfTest
http://hdl.handle.net/20.500.11769/26798Test -
9
المؤلفون: Umberto Vitolo, Pier Luigi Zinzani, Jens Kuhlmann, Francesco d'Amore, Pierre Soubeyran, Arne Kolstad, John Radford, Hervé Tilly, Mario Petrini, Gilles Salles, Achiel Van Hoof, Marinus H. J. van Oers, Anton Hagenbeek, Marcos Gonzalez Diaz, Catherine Sebban, Angelika Bischof-Delaloye, Peter C. Huijgens, Ama Z. S. Rohatiner, Wim H. van der Putten, Franck Morschhauser
المساهمون: Hematology, CCA - Innovative therapy, AII - Amsterdam institute for Infection and Immunity, CCA -Cancer Center Amsterdam, Clinical Haematology, Morschhauser F, Radford J, Van Hoof A, Vitolo U, Soubeyran P, Tilly H, Huijgens PC, Kolstad A, d'Amore F, Gonzalez Diaz M, Petrini M, Sebban C, Zinzani PL, van Oers MH, van Putten W, Bischof-Delaloye A, Rohatiner A, Salles G, Kuhlmann J, Hagenbeek A.
المصدر: Morschhauser, F, Radford, J, Van Hoof, A, Vitolo, U, Soubeyran, P, Tilly, H, Huijgens, P C, Kolstad, A, d'Amore, F, Gonzalez Diaz, M, Petrini, M, Sebban, C, Zinzani, P L, van Oers, M H J, van Putten, W, Bischof-Delaloye, A, Rohatiner, A, Salles, G, Kuhlmann, J & Hagenbeek, A 2008, ' Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma ', Journal of Clinical Oncology, vol. 26, no. 32, pp. 5156-64 . https://doi.org/10.1200/JCO.2008.17.2015Test
Journal of Clinical Oncology, 26(32), 5156-5164. American Society of Clinical Oncology
Journal of clinical oncology, 26(32), 5156-5164. American Society of Clinical Oncology
Morschhauser, F, Radford, J, van Hoof, A, Vitolo, U, Soubeyran, P, Tilly, H, Huijgens, P C, Kolstad, A, d'Amore, F, Gonzalez, D M, Petrini, M, Sebban, C, Zinzani, P L, van Oers, M H, van Putten, W L, Bischof-Delaloye, A, Rohatiner, A, Salles, G, Kuhlmann, J & Hagenbeek, A 2008, ' Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma ', Journal of Clinical Oncology, vol. 26, no. 32, pp. 5156-5164 . https://doi.org/10.1200/JCO.2008.17.2015Testمصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Canada, Time Factors, medicine.medical_treatment, Follicular lymphoma, Ibritumomab tiuxetan, Disease-Free Survival, law.invention, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Lymphoma, Follicular, Aged, Neoplasm Staging, CD20, biology, business.industry, Antibodies, Monoclonal, Middle Aged, Radioimmunotherapy, medicine.disease, Antigens, CD20, Surgery, Radiation therapy, Europe, Treatment Outcome, Oncology, Chemotherapy, Adjuvant, biology.protein, Rituximab, Female, Radiotherapy, Adjuvant, Nuclear medicine, business, medicine.drug
وصف الملف: STAMPA
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b763838fc6e902b56d4de29882691628Test
https://pure.au.dk/portal/da/publications/phase-iii-trial-of-consolidation-therapy-with-yttrium90ibritumomab-tiuxetan-compared-with-no-additional-therapy-after-first-remission-in-advanced-follicular-lymphomaTest(ed34f880-f693-11dd-8f9a-000ea68e967b).html